Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis

Ahmadi, 2018, Altered expression of MALAT1 lncRNA in chronic lymphocytic leukemia patients, correlation with cytogenetic findings, Blood Res., 53, 320, 10.5045/br.2018.53.4.320 Amodio, 2018, MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches, J. Hematol. Oncol., 11, 10.1186/s13045-018-0606-4 Amodio, 2018, Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity, Leukemia, 32, 1948, 10.1038/s41375-018-0067-3 Arshi, 2018, Expression analysis of MALAT1, GAS5, SRA, and NEAT1 lncRNAs in breast cancer tissues from young women and women over 45 years of age, Mol. Ther. Nucleic Acids, 12, 751, 10.1016/j.omtn.2018.07.014 Arun, 2018, Comprehensive analysis of aberrantly expressed lncRNAs and construction of ceRNA network in gastric cancer, Oncotarget, 9, 18386, 10.18632/oncotarget.24841 Bai, 2018, Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway, Exp. Cell Res., 366, 161, 10.1016/j.yexcr.2018.03.014 Bamodu, 2016, Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448, BMC Cancer, 16, 160, 10.1186/s12885-016-2108-5 Barbagallo, 2018, LncRNA UCA1, upregulated in CRC biopsies and downregulated in serum exosomes, controls mRNA expression by RNA-RNA interactions, Mol. Ther. Nucleic Acids, vol. 12, 229, 10.1016/j.omtn.2018.05.009 Brown, 2014, Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix, Nat. Struct. Mol. Biol., 21, 633, 10.1038/nsmb.2844 Cai, 2016, Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcoma, J. Orthop. Res., 34, 932, 10.1002/jor.23105 Cai, 2018, Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma, Cancer Med., 7, 1404, 10.1002/cam4.1384 Cao, 2015, MALAT1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma, Cancer Biomark., 15, 717, 10.3233/CBM-150513 Cao, 2016, Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function, Am. J. Cancer Res., 6, 2561 Chang, 2018, Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis, J. Cell. Physiol., 233, 3384, 10.1002/jcp.26185 Chang, 2018, MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS, Oncol. Targets Ther., 11, 3461, 10.2147/OTT.S164131 Chen, 2014, Cisplatin and paclitaxel target significant long noncoding RNAs in laryngeal squamous cell carcinoma, Med. Oncol., vol. 31, 246, 10.1007/s12032-014-0246-7 Chen, 2016, Plasma long non-coding RNA MALAT1 is associated with distant metastasis in patients with epithelial ovarian cancer, Oncol. Lett., 12, 1361, 10.3892/ol.2016.4800 Chen, 2017, The role of MALAT-1 in the invasion and metastasis of gastric cancer, Scand. J. Gastroenterol., 52, 790, 10.1080/00365521.2017.1280531 Chen, 2017, Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction, J. Physiol. Sci., 67, 577, 10.1007/s12576-016-0486-8 Chen, 2017, MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression, Oncotarget, 8, 22783, 10.18632/oncotarget.15199 Chen, 2017, MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway, Oncotarget, 8, 94317, 10.18632/oncotarget.21693 Chen, 2018, LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway, Anti-Cancer Drugs, 29, 767, 10.1097/CAD.0000000000000645 Chen, 2018, LncRNA MALAT1 promotes cancer metastasis in osteosarcoma via activation of the PI3K-Akt signaling pathway, Cell. Physiol. Biochem., 51, 1313, 10.1159/000495550 Cheng, 2018, Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer, PLoS ONE, e0192264, 13 Cho, 2014, MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression, BMC Cancer, vol. 14, 809, 10.1186/1471-2407-14-809 Chou, 2016, MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42, Biochem. Biophys. Res. Commun., 472, 262, 10.1016/j.bbrc.2016.02.102 Chu, 2017, MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma, Exp. Mol. Pathol., 103, 229, 10.1016/j.yexmp.2017.10.002 Cui, 2016, Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer, Tumour Biol., 37, 4127, 10.1007/s13277-015-4261-x Cui, 2018, Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer, Oncol. Lett., 16, 4821 Dai, 2019, Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells, Pathol. Res. Pract., 215, 712, 10.1016/j.prp.2019.01.011 Deng, 2016, Overexpressed MALAT1 promotes invasion and metastasis of gastric cancer cells via increasing EGFL7 expression, Life Sci., vol. 157, 38, 10.1016/j.lfs.2016.05.041 Dong, 2015, MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway, Tumour Biol., 36, 1477, 10.1007/s13277-014-2631-4 Du, 2018, TGF-? regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma, Biomed. Pharmacother., 99, 688, 10.1016/j.biopha.2018.01.120 Duan, 2016, Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer, Oncotarget, 7, 78850, 10.18632/oncotarget.12880 Eastlack, 2018, Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer, PLoS ONE, 13, e0198945, 10.1371/journal.pone.0198945 Eissmann, 2012, Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development, RNA Biol., 9, 1076, 10.4161/rna.21089 Engreitz, 2014, RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites, Cell, 159, 188, 10.1016/j.cell.2014.08.018 Fan, 2014, TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12, Clin. Cancer Res., 20, 1531, 10.1158/1078-0432.CCR-13-1455 Fang, 2015, 17β-Estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner, Biochem. Biophys. Res. Commun., 457, 500, 10.1016/j.bbrc.2014.12.114 Fang, 2016, Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins, BMC Cancer, 16, 706, 10.1186/s12885-016-2735-x Fang, 2018, LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation, Biomed. Pharmacother., 101, 536, 10.1016/j.biopha.2018.02.130 Feng, 2016, miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation, Oncotarget, 7, 16205, 10.18632/oncotarget.7578 Fu, 2017, Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma, Biochem. Biophys. Res. Commun., 492, 480, 10.1016/j.bbrc.2017.08.070 Gao, 2016, Long non-coding RNA MALAT1 is an independent prognostic factor of osteosarcoma, Eur. Rev. Med. Pharmacol. Sci., 20, 3561 Gao, 2017, LncRNA MALAT-1 elevates HMGB1 to promote autophagy resulting in inhibition of tumor cell apoptosis in multiple myeloma, J. Cell. Biochem., vol. 118, 3341, 10.1002/jcb.25987 Gao, 2018, The mechanism study of miR-125b in occurrence and progression of multiple myeloma, Cancer Med., 7, 134, 10.1002/cam4.1181 Gong, 2016, Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response, Tumour Biol., vol. 37, 8349, 10.1007/s13277-015-4497-5 Gong, 2017, Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer, Acta Pharmacol. Sin., 38, 581, 10.1038/aps.2016.164 Gordon, 2019, The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing, Mol. Carcinog., vol. 58, 196, 10.1002/mc.22919 Guo, 2010, Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion, Acta Biochim. Biophys. Sin. Shanghai, 42, 224, 10.1093/abbs/gmq008 Guo, 2015, MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation, Int. J. Clin. Exp. Pathol., 8, 15903 Guo, 2015, Regulation of MALAT1 expression by TDP43 controls the migration and invasion of non-small cell lung cancer cells in vitro, Biochem. Biophys. Res. Commun., 465, 293, 10.1016/j.bbrc.2015.08.027 Guo, 2015, Expression of MALAT1 in the peripheral whole blood of patients with lung cancer, Biomed. Rep., 3, 309, 10.3892/br.2015.422 Guo, 2018, Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/beta-catenin signaling pathway, Eur. Rev. Med. Pharmacol. Sci., 22, 3703 Gutschner, 2013, The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells, Cancer Res., 73, 1180, 10.1158/0008-5472.CAN-12-2850 Gyvyte, 2018, Identification of long intergenic non-coding RNAs (lincRNAs) deregulated in gastrointestinal stromal tumors (GISTs), PLoS ONE, 13, 10.1371/journal.pone.0209342 Han, 2013, Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder, Urology, 81, e1 Han, 2013, Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1, FEBS Lett., 587, 3875, 10.1016/j.febslet.2013.10.023 Han, 2016, EZH2 promotes cell migration and invasion but not alters cell prvoliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer, Oncotarget., vol.7, 11194, 10.18632/oncotarget.7156 Han, 2016, Downregulation of lncRNA-MALAT1 Affects Proliferation and the expression of stemness Markers in Glioma Stem Cell Line SHG139S, Cell. Mol. Neurobiol., 36, 1097, 10.1007/s10571-015-0303-6 Han, 2019, Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial–mesenchymal transition in human cervical cancer, J. Cell. Physiol., 234, 14170, 10.1002/jcp.28113 Handa, 2017, Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma, Br. J. Haematol., 179, 449, 10.1111/bjh.14882 He, 2017, Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma, Oncotarget, vol. 8, 41166, 10.18632/oncotarget.17083 He, 2019, Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling, J. Cell. Biochem., vol. 120, 2908, 10.1002/jcb.26823 Hirata, 2015, Long Noncoding RNA MALAT1 promotes aggressive renal cell Carcinoma through Ezh2 and Interacts with miR-205, Cancer Res., 75, 1322, 10.1158/0008-5472.CAN-14-2931 Hou, 2017, HBx-related long non-coding RNA MALAT1 promotes cell metastasis via up-regulating LTBP3 in hepatocellular carcinoma, Am. J. Cancer Res., 7, 845 Hou, 2017, The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1, Tumour Biol., 39, 10.1177/1010428317718135 Hu, 2015, Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma, J. Exp. Clin. Cancer Res., 34, 7, 10.1186/s13046-015-0123-z Hu, 2017, 17betaEstradiol treatment drives Sp1 to upregulate MALAT1 expression and epigenetically affects physiological processes in U2OS cells, Mol. Med. Rep., 15, 1335, 10.3892/mmr.2017.6115 Hu, 2018, Interaction of E3 Ubiquitin Ligase MARCH7 with Long Noncoding RNA MALAT1 and Autophagy-related Protein ATG7 Promotes Autophagy and Invasion in Ovarian Cancer, Cell. Physiol. Biochem., 47, 654, 10.1159/000490020 Hu, 2018, Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma, Leukemia, 32, 2250, 10.1038/s41375-018-0104-2 Huang, 2015, Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma, Oncol. Rep., 34, 2403, 10.3892/or.2015.4259 Huang, 2016, Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients, Biomed. Pharmacother., 83, 8, 10.1016/j.biopha.2016.05.044 Huang, 2016, MALAT1 promotes the proliferation and invasion of thyroid cancer cells via regulating the expression of IQGAP1, Biomed. Pharmacother., 83, 1, 10.1016/j.biopha.2016.05.039 Huang, 2016, Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer, Oncotarget, 7, 37957, 10.18632/oncotarget.9364 Huang, 2017, LncRNA-MALAT1 promotes angiogenesis of thyroid cancer by modulating tumor-associated macrophage FGF2 protein secretion, J. Cell. Biochem., 118, 4821, 10.1002/jcb.26153 Huang, 2017, Upregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia, Oncol. Rep., 38, 1353, 10.3892/or.2017.5802 Huang, 2018, MALAT1 modulates the autophagy of retinoblastoma cell through miR-124-mediated stx17 regulation, J. Cell. Biochem., 119, 3853, 10.1002/jcb.26464 Huang, 2018, A panel of serum noncoding RNAs for the diagnosis and monitoring of response to therapy in patients with breast cancer, Med. Sci. Monit., 24, 2476, 10.12659/MSM.909453 Huang, 2018, MALAT1 promotes angiogenesis of breast cancer, Oncol. Rep., vol. 40, 2683 Huang, 2019, lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progression, Oncoimmunology, 8, 10.1080/2162402X.2018.1518628 Huo, 2017, MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2, Oncotarget, 8, 46993, 10.18632/oncotarget.16551 Jadaliha, 2016, Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer, Oncotarget, 7, 40418, 10.18632/oncotarget.9622 Jen, 2017, Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression, Mol. Cancer, 16, 104, 10.1186/s12943-017-0674-z Ji, 2003, MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer, Oncogene, 22, 8031, 10.1038/sj.onc.1206928 Ji, 2013, Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/beta-catenin signal pathway, PLoS ONE, 8, e78700, 10.1371/journal.pone.0078700 Ji, 2014, Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex, Br. J. Cancer, 111, 736, 10.1038/bjc.2014.383 Ji, 2018, Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway, Biochem. Biophys. Res. Commun., 501, 33, 10.1016/j.bbrc.2018.04.116 Jiang, 2014, The role of MALAT1 correlates with HPV in cervical cancer, Oncol. Lett., 7, 2135, 10.3892/ol.2014.1996 Jiang, 2018, Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes renal cell carcinoma progression via sponging miRNA-429, Med. Sci. Monit., 24, 1794, 10.12659/MSM.909450 Jiang, 2018, Nuclear factor Erythroid 2-related Factor 2 (Nrf2) Inhibition: an emerging strategy in Cancer Therapy, J. Med. Chem., 62, 3840, 10.1021/acs.jmedchem.8b01121 Jiao, 2014, Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer, Oncol. Rep., vol. 32, 2485, 10.3892/or.2014.3518 Jiao, 2015, Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells, Int. J. Mol. Sci., 16, 6677, 10.3390/ijms16046677 Jiao, 2018, LncRNA MALAT1 promotes tumor growth and metastasis by targeting miR-124/foxq1 in bladder transitional cell carcinoma (BTCC), Am. J. Cancer Res., 8, 748 Jin, 2016, Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development, Tumour Biol., vol. 37, 7383, 10.1007/s13277-015-4605-6 Jin, 2017, LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway, Eur. Rev. Med. Pharmacol. Sci., 21, 3176 Kandoth, 2013, Mutational landscape and significance across 12 major cancer types, Nature, 502, 333, 10.1038/nature12634 Kang, 2018, Expression of UCA1 and MALAT1 long-chain non-coding RNAs in esophageal squamous cell carcinoma tissues is predictive of patient prognosis, Arch. Med. Sci., 14, 752 Kholghi Oskooei, 2018, Assessment of functional variants and expression of long noncoding RNAs in vitamin D receptor signaling in breast cancer, Cancer Manag. Res., 10, 3451, 10.2147/CMAR.S174244 Kim, 2017, Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma, Oncotarget, 8, 31305, 10.18632/oncotarget.15453 Kim, 2018, Long noncoding RNA MALAT1 suppresses breast cancer metastasis, Nat. Genet., vol. 50, 1705, 10.1038/s41588-018-0252-3 Kim, 2018, Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide, Nucleic Acids Res., 46, 1424, 10.1093/nar/gkx1221 Konishi, 2016, Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma, Cancer Sci., 107, 149, 10.1111/cas.12854 Kulkarni, 2018, Elevated miR-182-5p associates with renal cancer cell mitotic arrest through diminished MALAT-1 expression, Mol. Cancer Res., vol. 16, 1750, 10.1158/1541-7786.MCR-17-0762 Lai, 2012, Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation, Med. Oncol., 29, 1810, 10.1007/s12032-011-0004-z Latorre, 2016, The ribonucleic complex HuR-MALAT1 represses CD133 expression and suppresses epithelial–mesenchymal transition in breast cancer, Cancer Res., 76, 2626, 10.1158/0008-5472.CAN-15-2018 Lee, 2017, MALAT1 promoted invasiveness of gastric adenocarcinoma, BMC Cancer, 17, 46, 10.1186/s12885-016-2988-4 Lei, 2017, Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP, Oncol. Targets Ther., 10, 35, 10.2147/OTT.S112686 Li, Z., Ma, Z. & Xu, X., 2019, Long noncoding RNA MALAT1 correlates with cell viability and mobility by targeting miR223p in renal cell carcinoma via the PI3K/Akt pathway, Oncol. Rep., 41, 1113 Li, 2014, Activation of LTBP3 gene by a long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma, J. Biol. Chem., 289, 29365, 10.1074/jbc.M114.572693 Li, 2016, LncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204, Am. J. Cancer Res., 6, 1099 Li, 2016, Long noncoding RNA MALAT1 promotes aggressive pancreatic cancer proliferation and metastasis via the stimulation of autophagy, Mol. Cancer Ther., 15, 2232, 10.1158/1535-7163.MCT-16-0008 Li, 2016, Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma, Cancer Lett., 383, 28, 10.1016/j.canlet.2016.09.019 Li, 2017, High expression of long noncoding RNA MALAT1 indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer, Clin. Genitourin. Cancer, 15, 570, 10.1016/j.clgc.2017.05.001 Li, 2017, Down-regulation of miR-146b-5p by long noncoding RNA MALAT1 in hepatocellular carcinoma promotes cancer growth and metastasis, Oncotarget, 8, 28683, 10.18632/oncotarget.15640 Li, 2017, Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297, Cancer Cell Int., 17, 44, 10.1186/s12935-017-0408-8 Li, 2017, The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma, Biomed. Pharmacother., vol. 89, 939, 10.1016/j.biopha.2017.02.011 Li, 2017, MALAT1 is associated with poor response to oxaliplatin-based chemotherapy in colorectal cancer patients and promotes chemoresistance through EZH2. molcanther. 0591.2016, Mol. Cancer Ther., 16, 739, 10.1158/1535-7163.MCT-16-0591 Li, 2017, Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma, Oncotarget, 8, 106648, 10.18632/oncotarget.20678 Li, 2017, Associations between novel genetic variants in the promoter region of MALAT1 and risk of colorectal cancer, Oncotarget, 8, 92604, 10.18632/oncotarget.21507 Li, 2017, Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101, J. Neuro-Oncol., vol. 134, 19, 10.1007/s11060-017-2498-5 Li, 2017, Long noncoding RNA MALAT 1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression, J. Oral Pathol. Med., vol. 46, 583, 10.1111/jop.12538 Liang, 2017, MALAT1 induces tongue cancer cells' EMT and inhibits apoptosis through Wnt/beta-catenin signaling pathway, J. Oral Pathol. Med., 46, 98, 10.1111/jop.12466 Lin, 2018, Expression of metastasis-associated lung adenocarcinoma transcript 1 long non-coding RNA in vitro and in patients with non-small cell lung cancer, Oncol. Lett., 15, 9443 Lin, 2018, MALAT1 affects ovarian cancer cell behavior and patient survival, Oncol. Rep., 39, 2644 Liu, 2012, A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population, PLoS ONE, 7 Liu, 2015, Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1, Int. J. Biol. Macromol., 81, 491, 10.1016/j.ijbiomac.2015.08.016 Liu, 2016, The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer, Oncol. Rep., 36, 1679, 10.3892/or.2016.4909 Liu, 2016, Inhibition of the long non-coding RNA MALAT1 suppresses tumorigenicity and induces apoptosis in the human ovarian cancer SKOV3 cell line, Oncol. Lett., 11, 3686, 10.3892/ol.2016.4435 Liu, 2016, MiR-375 is epigenetically downregulated by HPV-16 E6 mediated DNMT1 upregulation and modulates EMT of cervical cancer cells by suppressing lncRNA MALAT1, PLoS ONE, 11 Liu, 2016, MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells, Tumour Biol., vol. 37, 633, 10.1007/s13277-015-3732-4 Liu, 2017, MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p, Cell Cycle, 16, 578, 10.1080/15384101.2017.1288324 Liu, 2017, The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma, Sci. Rep., 7, 5186, 10.1038/s41598-017-05274-4 Liu, 2018, Knockdown of long non-coding RNA MALAT1 inhibits growth and motility of human hepatoma cells via modulation of miR-195, J. Cell. Biochem., vol. 119, 1368, 10.1002/jcb.26297 Liu, 2018, Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value, Future Oncol., 14, 3015, 10.2217/fon-2018-0416 Liu, 2018, Knockdown of long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) inhibits proliferation, migration, and invasion and promotes apoptosis by targeting miR-124 in retinoblastoma, Oncol. Res., vol. 26, 581, 10.3727/096504017X14953948675403 Lu, 2015, Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial–mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract, Toxicol. Appl. Pharmacol., 289, 276, 10.1016/j.taap.2015.09.016 Lu, 2016, Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145, Tumour Biol., vol. 37, 1683, 10.1007/s13277-015-3946-5 Luan, 2016, Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22, Oncotarget, 7, 63901, 10.18632/oncotarget.11564 Luo, 2016, MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A, Oncotarget, 7, 54733, 10.18632/oncotarget.10752 Ma, 2015, Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma, Tumour Biol., 36, 3355, 10.1007/s13277-014-2969-7 Ma, 2018, Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy, Cancer Biomark., 22, 63, 10.3233/CBM-170917 Meseure, 2016, Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer, Br. J. Cancer, 114, 1395, 10.1038/bjc.2016.123 Miao, 2016, Clinical significance of long non-coding RNA MALAT1 expression in tissue and serum of breast cancer, Ann. Clin. Lab. Sci., vol. 46, 418 Okugawa, 2014, Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis, Carcinogenesis, vol. 35, 2731, 10.1093/carcin/bgu200 Pan, 2018, Long Non-Coding MALAT1 functions as a competing endogenous RNA to regulate vimentin expression by sponging miR-30a-5p in hepatocellular carcinoma, Cell. Physiol. Biochem., 50, 108, 10.1159/000493962 Pang, 2015, Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer, Tumour Biol., vol. 36, 2403, 10.1007/s13277-014-2850-8 Peng, 2016, A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer, Life Sci., 151, 235, 10.1016/j.lfs.2016.03.002 Peng, 2018, Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population, Gene, 642, 241, 10.1016/j.gene.2017.11.013 Pouyanrad, 2019, Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia, Gene, 692, 35, 10.1016/j.gene.2019.01.003 Pruszko, 2017, The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1, EMBO Rep., 18, 1331, 10.15252/embr.201643370 Qi, 2016, MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10, Oncotarget, 7, 12693, 10.18632/oncotarget.7281 Qiu, 2018, Exosomal Metastasis-associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and predicts poor prognosis in Epithelial Ovarian Cancer, Int. J. Biol. Sci., 14, 1960, 10.7150/ijbs.28048 Ren, 2013, Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer, J. Urol., 190, 2278, 10.1016/j.juro.2013.07.001 Ren, 2013, Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer, Eur. J. Cancer, 49, 2949, 10.1016/j.ejca.2013.04.026 Schmidt, 2011, The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth, J. Thorac. Oncol., 6, 1984, 10.1097/JTO.0b013e3182307eac Shen, 2015, Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer, J. Neuro-Oncol., vol. 121, 101, 10.1007/s11060-014-1613-0 Shen, 2019, Overexpression of MALAT1 contributes to cervical cancer progression by acting as a sponge of miR-429, J. Cell. Physiol., 234, 11219, 10.1002/jcp.27772 Shi, 2017, MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells, Cancer Biol. Ther., 18, 792, 10.1080/15384047.2017.1373214 Shi, 2018, The long non-coding RNA MALAT1 interacted with miR-218 modulates choriocarcinoma growth by targeting Fbxw8, Biomed. Pharmacother., 97, 543, 10.1016/j.biopha.2017.10.083 Shi, 2018, The plasma LncRNA acting as fingerprint in hilar cholangiocarcinoma, Cell. Physiol. Biochem., 49, 1694, 10.1159/000493613 Stamato, 2017, Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma, Oncotarget, 8, 106527, 10.18632/oncotarget.22507 Sun, 2018, Long noncoding RNA MALAT1 regulates HDAC4-mediated proliferation and apoptosis via decoying of miR-140-5p in osteosarcoma cells, Cancer Med., 7, 4584, 10.1002/cam4.1677 Sun, 2016, Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition, Mol. BioSyst., 12, 952, 10.1039/C5MB00685F Sun, 2017, Identification of a novel SYK/c-MYC/MALAT1 signaling pathway and its potential therapeutic value in ewing sarcoma, Clin. Cancer Res., 23, 4376, 10.1158/1078-0432.CCR-16-2185 Sun, 2017, Deregulation of miR-183 promotes melanoma development via lncRNA MALAT1 regulation and ITGB1 signal activation, Oncotarget, 8, 3509, 10.18632/oncotarget.13862 Sun, 2018, MIIP is downregulated in gastric cancer and its forced expression inhibits proliferation and invasion of gastric cancer cells in vitro and in vivo, Oncol. Targets Ther., 11, 8951, 10.2147/OTT.S173393 Sun, 2018, Prognostic significance of long non-coding RNA MALAT1 for predicting the recurrence and metastasis of gallbladder cancer and its effect on cell proliferation, migration, invasion, and apoptosis, J. Cell. Biochem., 119, 3099, 10.1002/jcb.26451 Sun, 2019, YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer, Oncogene, 38, 2627, 10.1038/s41388-018-0628-y Tan, 2017, Long Non-Coding RNA MALAT1 Interacts With miR-204 to Modulate Human Hilar Cholangiocarcinoma Proliferation, Migration, and Invasion by Targeting CXCR4, J. Cell. Biochem., 118, 3643, 10.1002/jcb.25862 Tang, 2018, LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling, Anti-Cancer Drugs, vol. 29, 725, 10.1097/CAD.0000000000000650 Tang, 2019, Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer, Cell. Signal., 57, 21, 10.1016/j.cellsig.2019.01.013 Tano, 2017, Identification of minimal p53 promoter region regulated by MALAT1 in human lung adenocarcinoma cells, Front. Genet., 8, 208, 10.3389/fgene.2017.00208 Tao, 2018, miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma, FASEB J., 32, 6330, 10.1096/fj.201800495RR Tee, 2014, The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1, Oncotarget, 5, 1793, 10.18632/oncotarget.1785 Tee, 2016, The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression, Oncotarget, 7, 8663, 10.18632/oncotarget.6675 Thiele, 2018, lncRNAs in non-malignant tissue have prognostic value in colorectal cancer, Int. J. Mol. Sci., 19, 10.3390/ijms19092672 Tian, 2014, Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma, Melanoma Res., vol. 24, 335, 10.1097/CMR.0000000000000080 Tian, 2018, MALAT1-miR663a negative feedback loop in colon cancer cell functions through direct miRNA-lncRNA binding, Cell Death Dis., 9, 857, 10.1038/s41419-018-0925-y Toraih, 2018, Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma, Biomed. Pharmacother., vol. 102, 653, 10.1016/j.biopha.2018.03.105 Tripathi, 2010, The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation, Mol. Cell, 39, 925, 10.1016/j.molcel.2010.08.011 Vassallo, 2016, WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1, Oncogene, 35, 12, 10.1038/onc.2015.61 Wang, 2014, MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF, Biomed. Pharmacother., 68, 557, 10.1016/j.biopha.2014.04.007 Wang, 2014, Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer, Cell. Signal., 26, 1048, 10.1016/j.cellsig.2014.01.022 Wang, 2015, LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer, Oncotarget, 6, 41045, 10.18632/oncotarget.5728 Wang, 2016, The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer, J. Cell. Mol. Med., 20, 2299, 10.1111/jcmm.12920 Wang, 2016, Long non-coding RNA Malat1 promotes gallbladder cancer development by acting as a molecular sponge to regulate miR-206, Oncotarget, 7, 37857, 10.18632/oncotarget.9347 Wang, 2016, Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting beta-catenin via Ezh2, Oncotarget, 7, 25668, 10.18632/oncotarget.8257 Wang, 2016, LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2, J. Transl. Med., 14, 10.1186/s12967-016-1100-9 Wang, 2017, lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients, Oncotarget, vol. 8, 95108, 10.18632/oncotarget.19345 Wang, 2017, A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis, BMC Cancer, 17, 167, 10.1186/s12885-017-3151-6 Wang, 2017, Preclinical study using malat1 small interfering RNA or androgen receptor splicing variant 7 degradation enhancer ASC-J9® to suppress enzalutamide-resistant prostate cancer progression, Eur. Urol., 72, 835, 10.1016/j.eururo.2017.04.005 Wang, 2017, Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells, Oncotarget, 8, 59417, 10.18632/oncotarget.19727 Wang, 2017, MiR-204/ZEB2 axis functions as key mediator for MALAT1-induced epithelial-mesenchymal transition in breast cancer, Tumour Biol., 39, 10.1177/1010428317690998 Wang, 2018, Association of twelve polymorphisms in three onco-lncRNA genes with hepatocellular cancer risk and prognosis: a case-control study, World J. Gastroenterol., 24, 2482, 10.3748/wjg.v24.i23.2482 Wang, 2018, Association of polymorphisms in MALAT1 with risk of coronary atherosclerotic heart disease in a Chinese population, Lipids Health Dis., 17, 10.1186/s12944-018-0728-2 Wang, 2018, MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer, Oncotarget, 9, 7501, 10.18632/oncotarget.23483 Wang, 2018, MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway, Eur. Rev. Med. Pharmacol. Sci., 22, 7653 Wang, 2018, TGF-beta-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions, Cancer Lett., 436, 52, 10.1016/j.canlet.2018.08.009 Ward, 2012, HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants, Nucleic Acids Res., 40, D930, 10.1093/nar/gkr917 Weber, 2013, Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer, BMC Res. Notes, 6, 518, 10.1186/1756-0500-6-518 Wu, 2014, MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway, Cancer Biol. Ther., 15, 806, 10.4161/cbt.28584 Wu, 2014, Activating transcription factor 3 promotes colon cancer metastasis, Tumour Biol., 35, 8329, 10.1007/s13277-014-2044-4 Wu, 2016, HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2, Sci. Rep., 6, 36045, 10.1038/srep36045 Wu, 2017, Long non-coding RNA MALAT1 is upregulated and involved in cell proliferation, migration and apoptosis in ovarian cancer, Exp. Ther. Med., 13, 3055, 10.3892/etm.2017.4304 Wu, 2018, MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation, Mol. Carcinog., 57, 1421, 10.1002/mc.22868 Wu, 2018, LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis, J. Cell. Physiol., 233, 6750, 10.1002/jcp.26383 Xi, Z., Si, J. & Nan, J., 2019, LncRNA MALAT1 potentiates autophagyassociated cisplatin resistance by regulating the microRNA30b/autophagyrelated gene 5 axis in gastric cancer, Int. J. Oncol., 54, 239 Xia, 2016, The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis, Oncotarget, vol. 7, 56209, 10.18632/oncotarget.10941 Xia, 2018, Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells, Eur. J. Pharmacol., 830, 59, 10.1016/j.ejphar.2018.04.027 Xiang, 2016, Silencing of long non-coding RNA MALAT1 Promotes Apoptosis of Glioma Cells, J. Korean Med. Sci., 31, 688, 10.3346/jkms.2016.31.5.688 Xiang, 2017, MALAT1 modulates TGF-β1-induced Endothelial-to-mesenchymal transition through downregulation of miR-145, Cell. Physiol. Biochem., 42, 357, 10.1159/000477479 Xiao, 2015, LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma, Oncotarget, 6, 38005, 10.18632/oncotarget.5357 Xie, 2017, LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells, J. Cancer, 8, 3803, 10.7150/jca.21228 Xiong, 2018, Chronic oxymatrine treatment induces resistance and epithelial-mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells, Oncol. Rep., vol. 39, 967 Xiping, 2018, Roles of MALAT1 in development and migration of triple negative and Her-2 positive breast cancer, Oncotarget, 9, 2255, 10.18632/oncotarget.23370 Xu, 2015, Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer, Int. J. Clin. Exp. Pathol., 8, 4881 Xu, 2018, The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9, Mol. Med., 24, 52, 10.1186/s10020-018-0050-5 Xue, 2018, Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12, J. Cell. Mol. Med., 22, 3223, 10.1111/jcmm.13604 Yan, 2019, IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer, Int. J. Oncol., 54, 7 Yang, 2015, High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion, Eur. Rev. Med. Pharmacol. Sci., 19, 3187 Yang, 2015, MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9, Biochim. Biophys. Acta, 1852, 166, 10.1016/j.bbadis.2014.11.013 Yang, 2018, Polyphyllin I modulates MALAT1/STAT3 signaling to induce apoptosis in gefitinib-resistant non-small cell lung cancer, Toxicol. Appl. Pharmacol., 356, 1, 10.1016/j.taap.2018.07.031 Yao, 2016, Upregulation of MALAT-1 and its association with survival rate and the effect on cell cycle and migration in patients with esophageal squamous cell carcinoma, Tumour Biol., vol. 37, 4305, 10.1007/s13277-015-4223-3 Yazarlou, 2018, Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer, Cancer Manag. Res., 10, 6357, 10.2147/CMAR.S186108 Yin, 2010, ATF3, an adaptive-response gene, enhances TGFβ signaling and cancer-initiating cell features in breast cancer cells, J. Cell Sci., 123, 3558, 10.1242/jcs.064915 Ying, 2012, Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition, Mol. BioSyst., vol. 8, 2289, 10.1039/c2mb25070e Yiren, 2017, Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer, Mol. Cancer, 16, 174, 10.1186/s12943-017-0743-3 Yoshimoto, 2016, MALAT1 long non-coding RNA in cancer, Biochim. Biophys. Acta, 1859, 192, 10.1016/j.bbagrm.2015.09.012 Yu, 2018, Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer, Oncogene, vol. 1 Yuan, 2016, The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy, Biochem. Biophys. Res. Commun., 478, 1067, 10.1016/j.bbrc.2016.08.065 Yuan, 2019, LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression, Eur. Rev. Med. Pharmacol. Sci., vol. 23, 198 Zhan, 2018, Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer, Mol. Cancer, 17, 142, 10.1186/s12943-018-0893-y Zhang, 2015, Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma, Tumour Biol., vol. 36, 2947, 10.1007/s13277-014-2925-6 Zhang, 2016, Exosomal long noncoding rnas are differentially expressed in the cervicovaginal lavage samples of cervical cancer patients, J. Clin. Lab. Anal., 30, 1116, 10.1002/jcla.21990 Zhang, 2017, The use of lncRNA analysis for stratification management of prognostic risk in patients with NSCLC, Eur. Rev. Med. Pharmacol. Sci., 21, 115 Zhang, 2017, Effects of miRNA-143 and the non-coding RNA MALAT1 on the pathogenesis and metastasis of HeLa cells, Genet. Mol. Res., 16 Zhang, 2017, Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer, Biochem. Biophys. Res. Commun., 490, 406, 10.1016/j.bbrc.2017.06.055 Zhang, 2017, MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1, Biomed. Pharmacother., vol. 93, 1065, 10.1016/j.biopha.2017.07.005 Zhang, 2017, MiR-216a decreases MALAT1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells, Biochem. Biophys. Res. Commun., vol. 483, 816, 10.1016/j.bbrc.2016.12.167 Zhang, 2017, Targeting the long noncoding RNA MALAT1 blocks the pro-angiogenic effects of osteosarcoma and suppresses tumour growth, Int. J. Biol. Sci., 13, 1398, 10.7150/ijbs.22249 Zhang, 2018, Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer, Oncol. Targets Ther., 11, 291, 10.2147/OTT.S155134 Zhao, 2014, 17β-estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level, Biochem. Biophys. Res. Commun., vol. 445, 388, 10.1016/j.bbrc.2014.02.006 Zhao, 2018, Association study of genetic variation of lncRNA MALAT1 with carcinogenesis of colorectal cancer, Cancer Manag. Res., 10, 6257, 10.2147/CMAR.S177244 Zhao, 2018, The functional pathway analysis and clinical significance of miR-20a and its related lncRNAs in breast cancer, Cell. Signal., 51, 152, 10.1016/j.cellsig.2018.08.004 Zheng, 2014, High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer, Int. J. Clin. Exp. Pathol., 7, 3174 Zheng, 2018, IL-8 secreted from M2 macrophages promoted prostate tumorigenesis via STAT3/MALAT1 pathway, Int. J. Mol. Sci., 20, 10.3390/ijms20010098 Zheng, 2019, Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer, Biosci. Rep., 39, 10.1042/BSR20181284 Zhou, 2015, Long non coding RNA MALAT1 promotes tumor growth and metastasis by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma, Sci. Rep., 5, 15972, 10.1038/srep15972 Zhou, 2016, The long noncoding RNA MALAT-1 is highly expressed in ovarian cancer and induces cell growth and migration, PLoS ONE, 11 Zhou, 2018, Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling, J. Cell. Physiol., vol. 233, 5805, 10.1002/jcp.26357 Zhuo, 2018, A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis, BMC Cancer, 18, 1032, 10.1186/s12885-018-4954-9 Zidan, 2018, Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer, Cancer Genet., vol. 220, 32, 10.1016/j.cancergen.2017.11.005 Zou, 2016, Long non-coding RNA MALAT1 is up-regulated in ovarian cancer tissue and promotes SK-OV-3 cell proliferation and invasion, Neoplasma, 63, 865, 10.4149/neo_2016_605 Zuo, 2017, Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer, Biomed. Pharmacother., 95, 922, 10.1016/j.biopha.2017.09.005